trending Market Intelligence /marketintelligence/en/news-insights/trending/kbwwrr7xs_qtwawuxezbqw2 content esgSubNav
In This List

China Grand Pharmaceutical nonexecutive director dies

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


China Grand Pharmaceutical nonexecutive director dies

China Grand Pharmaceutical and Healthcare Holdings Ltd. said Lo Kai Lawrence, an independent nonexecutive director of the company, died May 11 due to an illness.

Lo had been on the company's board since 2008.

The Hong Kong-based company said it will appoint Lo's replacement as soon as possible as it is now noncompliant with the Hong Kong Stock Exchange's listing rules.

China Grand Pharmaceuticals manufactures and distributes pharmaceutical preparations, medical devices, biotechnology products and nutrition products.